UNSPSC 51102811: Bacitracin/hydrocortisone/neomycin/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102811 Bacitracin/hydrocortisone/neomycin/polymyxin B is a Commodity code that nominally covers topical antibiotic ointments, yet recent state and local solicitations tagged with this code show little alignment with the product name. The most recent opportunities under this code involve pharmaceuticals and medical supplies more broadly: Seminole County, Florida's IFB for naloxone and drug deactivation systems; the City of Tampa's ITB for medical and first aid supplies including respiratory equipment, cardiac monitoring devices, and medical consumables for the Fire Department Rescue Division; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities; and the Texas Health and Human Services Commission's RFI regarding direct-to-manufacturer prescription fulfillment programs. The issuing bodies include county health departments, municipal fire services, state cooperative purchasing alliances, and state health agencies — a mix of local procurement offices and statewide cooperative vehicles.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, reflecting both single-jurisdiction procurement (Seminole County, Tampa) and multistate cooperative arrangements (MMCAP, Texas HHS). Representative recent opportunities include Seminole County's naloxone procurement (IFB 60459723LAS, response due July 26, 2023, seeking 1,900 units annually with quarterly deliveries), the City of Tampa's medical and first aid supplies bid (ITB 26P00145, due March 13, 2026, estimated contract value $700,000, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000), and MMCAP's generic pharmaceutical and OTC products RFP (RFP S1070000015802, due March 26, 2026, effective July 1, 2026, requiring vendors to maintain relationships with authorized wholesalers and certify cGMP and Drug Supply Chain Security Act compliance). The code appears poorly matched to actual procurement activity, with recent opportunities focusing on emergency response supplies, broader pharmaceutical supply chains, and OTC products rather than the specific topical antibiotic ointment the code nominally describes.